Literature DB >> 19347398

Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner.

Jessica C Walrath1, Kristi Fox, Erika Truffer, W Gregory Alvord, Octavio A Quiñones, Karlyne M Reilly.   

Abstract

Neurofibromatosis type 1 (NF1) is one of the most common human genetic diseases affecting the nervous system and predisposes individuals to cancer, including peripheral nerve sheath tumors (PNSTs) and astrocytomas. Modifiers in the genetic background affect the severity of the disease and we have previously mapped two modifier loci, Nstr1 and Nstr2, that influence resistance to PNSTs in the Nf1-/+;Trp53-/+cis mouse model of NF1. We report here the analysis of Nstr1 in isolation from other epistatic loci using a chromosome substitution strain, and further show that a modifier locus (or loci) on chromosome 19 influences resistance to both PNSTs and astrocytomas. This modifier locus interacts with sex, resulting in sex-specific modification of tumors. Allele variability on chromosome 19 affects both the timing and the penetrance of the growth of different tumor types associated with NF1, specifically PNSTs and astrocytoma. These results indicate that modifiers of cancer susceptibility interact and affect tumorigenesis under different genetic conditions and demonstrate the power of chromosome substitution strains to study genetic modifiers.

Entities:  

Mesh:

Year:  2009        PMID: 19347398      PMCID: PMC2713021          DOI: 10.1007/s00335-009-9179-4

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  9 in total

1.  Mouse models of tumor development in neurofibromatosis type 1.

Authors:  K Cichowski; T S Shih; E Schmitt; S Santiago; K Reilly; M E McLaughlin; R T Bronson; T Jacks
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

2.  Mouse tumor model for neurofibromatosis type 1.

Authors:  K S Vogel; L J Klesse; S Velasco-Miguel; K Meyers; E J Rushing; L F Parada
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

Review 3.  Analysing complex genetic traits with chromosome substitution strains.

Authors:  J H Nadeau; J B Singer; A Matin; E S Lander
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

4.  An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model.

Authors:  Karlyne M Reilly; Karl W Broman; Roderick T Bronson; Shirley Tsang; Dagan A Loisel; Emily S Christy; Zhonghe Sun; John Diehl; David J Munroe; Robert G Tuskan
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

5.  Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.

Authors:  K M Reilly; D A Loisel; R T Bronson; M E McLaughlin; T Jacks
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

6.  The importance of genome architecture in cancer susceptibility: location, location, location.

Authors:  Karlyne M Reilly
Journal:  Cell Cycle       Date:  2004-11-30       Impact factor: 4.534

7.  Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.

Authors:  A G Menon; K M Anderson; V M Riccardi; R Y Chung; J M Whaley; D W Yandell; G E Farmer; R N Freiman; J K Lee; F P Li
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

8.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.

Authors:  D F Easton; M A Ponder; S M Huson; B A Ponder
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

9.  Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects.

Authors:  Karlyne M Reilly; Robert G Tuskan; Emily Christy; Dagan A Loisel; Jeremy Ledger; Roderick T Bronson; C Dahlem Smith; Shirley Tsang; David J Munroe; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-19       Impact factor: 11.205

  9 in total
  21 in total

1.  Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5.

Authors:  Jessica Amlin-Van Schaick; Sungjin Kim; Karl W Broman; Karlyne M Reilly
Journal:  Mamm Genome       Date:  2011-12-08       Impact factor: 2.957

2.  EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation.

Authors:  J Wu; W Liu; J P Williams; N Ratner
Journal:  Oncogene       Date:  2016-10-17       Impact factor: 9.867

Review 3.  Genetically engineered mouse models in cancer research.

Authors:  Jessica C Walrath; Jessica J Hawes; Terry Van Dyke; Karlyne M Reilly
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

4.  The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.

Authors:  Nicole M Warrington; Tao Sun; Jingqin Luo; Robert C McKinstry; Patricia C Parkin; Sara Ganzhorn; Debra Spoljaric; Anne C Albers; Amanda Merkelson; Douglas R Stewart; David A Stevenson; David Viskochil; Todd E Druley; Jason T Forys; Karlyne M Reilly; Michael J Fisher; Uri Tabori; Jeffrey C Allen; Joshua D Schiffman; David H Gutmann; Joshua B Rubin
Journal:  Cancer Res       Date:  2014-11-07       Impact factor: 12.701

5.  Exploring the genetic basis for clinical variation in neurofibromatosis type 1.

Authors:  David H Gutmann
Journal:  Expert Rev Neurother       Date:  2016-05-30       Impact factor: 4.618

6.  EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.

Authors:  J Wu; D M Patmore; E Jousma; D W Eaves; K Breving; A V Patel; E B Schwartz; J R Fuchs; T P Cripe; A O Stemmer-Rachamimov; N Ratner
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

Review 7.  Chromosome substitution strains: gene discovery, functional analysis, and systems studies.

Authors:  Joseph H Nadeau; Jiri Forejt; Toyoyuki Takada; Toshihiko Shiroishi
Journal:  Mamm Genome       Date:  2012-09-08       Impact factor: 2.957

8.  Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males.

Authors:  Tao Sun; Nicole M Warrington; Jingqin Luo; Michael D Brooks; Sonika Dahiya; Steven C Snyder; Rajarshi Sengupta; Joshua B Rubin
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

9.  A framework for detecting and characterizing genetic background-dependent imprinting effects.

Authors:  Jason B Wolf; James M Cheverud
Journal:  Mamm Genome       Date:  2009-08-06       Impact factor: 2.957

Review 10.  Contextual signaling in cancer.

Authors:  Laura J Smithson; Corina Anastasaki; Ran Chen; Joseph A Toonen; Sidney B Williams; David H Gutmann
Journal:  Semin Cell Dev Biol       Date:  2016-06-03       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.